These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3956055)

  • 1. Disposition of nomifensine after acute and prolonged dosing.
    Lindberg RL; Syvälahti EK; Pihlajamäki KK
    Clin Pharmacol Ther; 1986 Apr; 39(4):384-8. PubMed ID: 3956055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of nomifensine after oral and intravenous administration.
    Lindberg RL; Syvälahti EK
    Clin Pharmacol Ther; 1986 Apr; 39(4):378-83. PubMed ID: 3956054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-pass metabolism of nomifensine in dogs.
    Lindberg R; Sellman R; Iisalo E
    Eur J Drug Metab Pharmacokinet; 1985; 10(1):21-5. PubMed ID: 4029216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics and bioavailability of nomifensine maleate in healthy men.
    Lassman HB; Puri SK; Ho I; Sabo R; Rosenkilde HC
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):26-32. PubMed ID: 6715299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imipramine disposition in users of oral contraceptive steroids.
    Abernethy DR; Greenblatt DJ; Shader RI
    Clin Pharmacol Ther; 1984 Jun; 35(6):792-7. PubMed ID: 6734030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of nomifensine. Comparison of pharmacokinetics and pharmacodynamics using computer pharmaco-EEG.
    Saletu B; Grünberger J; Linzmayer L; Taeuber K
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():43-72. PubMed ID: 7129805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of dose, route, and repeated dosing on the disposition and kinetics of tetrabromobisphenol A in male F-344 rats.
    Kuester RK; Sólyom AM; Rodriguez VP; Sipes IG
    Toxicol Sci; 2007 Apr; 96(2):237-45. PubMed ID: 17234645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics and metabolism of nomifensine.
    Heptner W; Hornke I; Uihlein M
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):21-5. PubMed ID: 6370971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparative disposition of nomifensine (Merital) in the pregnant and non-pregnant rat.
    Ings RM
    Arch Int Pharmacodyn Ther; 1979 Dec; 242(2):180-95. PubMed ID: 543752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Felodipine kinetics in healthy men.
    Edgar B; Regårdh CG; Johnsson G; Johansson L; Lundborg P; Löfberg I; Rönn O
    Clin Pharmacol Ther; 1985 Aug; 38(2):205-11. PubMed ID: 4017422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isosorbide 5-mononitrate and isosorbide 2-mononitrate kinetics after intravenous and oral dosing.
    Straehl P; Galeazzi RL; Soliva M
    Clin Pharmacol Ther; 1984 Oct; 36(4):485-92. PubMed ID: 6478734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine kinetics in renal transplantation.
    Ptachcinski RJ; Venkataramanan R; Rosenthal JT; Burckart GJ; Taylor RJ; Hakala TR
    Clin Pharmacol Ther; 1985 Sep; 38(3):296-300. PubMed ID: 3896612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers.
    Frydman AM; Le Roux Y; Lefebvre MA; Djebbar F; Fourtillan JB; Gaillot J
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():65-79. PubMed ID: 3458699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of indomethacin.
    Alván G; Orme M; Bertilsson L; Ekstrand R; Palmér L
    Clin Pharmacol Ther; 1975 Sep; 18(3):364-73. PubMed ID: 1100305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers.
    Debbas NM; Jackson SH; Shah K; Abrams SM; Johnston A; Turner P
    Br J Clin Pharmacol; 1986 Apr; 21(4):385-8. PubMed ID: 3707812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of nomifensine in impaired renal function.
    Ringoir S; Lameire N; Munche M; Heptner W; Taeuber K
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):129S-134S. PubMed ID: 334214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low oral bioavailability and pharmacokinetics of senkyunolide a, a major bioactive component in Rhizoma Chuanxiong, in the rat.
    Yan R; Lin G; Ko NL; Tam YK
    Ther Drug Monit; 2007 Feb; 29(1):49-56. PubMed ID: 17304150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buccal delivery of an alpha 2-adrenergic receptor antagonist, atipamezole, in humans.
    Huupponen R; Karhuvaara S; Anttila M; Vuorilehto L; Scheinin H
    Clin Pharmacol Ther; 1995 Nov; 58(5):506-11. PubMed ID: 7586944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.